
First paragraph: The idea of tobacco harm reduction -- that smokers who cannot wean themselves off nicotine should be encouraged to adopt less harmful ways of consuming it -- has much to recommend it. It avoids the trap of making the excellent (complete cessation) the enemy of the good (reduced harm) and provides a way forward where otherwise there is only a cruel impasse. It also provides a clear focus on disease and premature death -- rather than tobacco addiction or corporate power -- and this enemy, like so many medical problems before it, will be defeated with rigorous evidence, effective medicines, and skilled treatment.
330, Drug Industry, Health Policy, Smoking Prevention and control, Smoking Prevention, Tobacco Industry, Smoking cessation, Public-Private Sector Partnerships, Tobacco Use Cessation Devices, United Kingdom, Health education, Harm Reduction, Advertising, Humans, Smoking Cessation, Tobacco habit Treatment
330, Drug Industry, Health Policy, Smoking Prevention and control, Smoking Prevention, Tobacco Industry, Smoking cessation, Public-Private Sector Partnerships, Tobacco Use Cessation Devices, United Kingdom, Health education, Harm Reduction, Advertising, Humans, Smoking Cessation, Tobacco habit Treatment
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 14 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
